Loading...
Drug Repositioning of the α(1)-Adrenergic Receptor Antagonist Naftopidil: A Potential New Anti-Cancer Drug?
Failure of conventional treatments is often observed in cancer management and this requires the development of alternative therapeutic strategies. However, new drug development is known to be a high-failure process because of the possibility of a lower efficacy than expected for the drug or appearan...
Na minha lista:
| Udgivet i: | Int J Mol Sci |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7432507/ https://ncbi.nlm.nih.gov/pubmed/32727149 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21155339 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|